{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T06:36:51Z","timestamp":1793342211155,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Basic Research Program of Department of Science and Technology of Qinghai Province","award":["2025-ZJ-726"],"award-info":[{"award-number":["2025-ZJ-726"]}]},{"name":"Qinghai Province obstetrics and gynecology disease clinical medical research center","award":["2024-SF-L03"],"award-info":[{"award-number":["2024-SF-L03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-33111-6","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T18:28:18Z","timestamp":1765996098000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Ginkgetin reverses cisplatin resistance in cervical cancer by regulating the Nrf2\/HO-1 signaling pathway to induce ferroptosis"],"prefix":"10.1038","volume":"16","author":[{"given":"Fei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liehong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"33111_CR1","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.canlet.2020.10.034","volume":"497","author":"Y Yuan","year":"2021","unstructured":"Yuan, Y. et al. HPV post-infection microenvironment and cervical cancer. Cancer Lett. 497, 243\u2013254 (2021).","journal-title":"Cancer Lett."},{"key":"33111_CR2","doi-asserted-by":"crossref","unstructured":"Perkins, R. B. et al. Cervical cancer screening: A review.  JAMA. 330(6), 547\u2013558 (2023).","DOI":"10.1001\/jama.2023.13174"},{"issue":"12","key":"33111_CR3","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.6004\/jnccn.2023.0062","volume":"21","author":"NR Abu-Rustum","year":"2023","unstructured":"Abu-Rustum, N. R. et al. NCCN Guidelines\u00ae insights: cervical Cancer, version 1.2024. J. Natl. Compr. Cancer Netw. 21 (12), 1224\u20131233 (2023).","journal-title":"J. Natl. Compr. Cancer Netw."},{"issue":"4","key":"33111_CR4","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang, X., Stockwell, B. R. & Conrad, M. Ferroptosis: mechanisms, biology and role in disease. Nat. Rev. Mol. Cell. Biol. 22 (4), 266\u2013282. https:\/\/doi.org\/10.1038\/s41580-020-00324-8 (2021).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"4","key":"33111_CR5","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1158\/2159-8290.CD-20-1638","volume":"11","author":"M Aldea","year":"2021","unstructured":"Aldea, M. et al. Overcoming resistance to tumor-targeted and immune-targeted therapies. Cancer Discov. 11 (4), 874\u2013899 (2021).","journal-title":"Cancer Discov"},{"issue":"4","key":"33111_CR6","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","volume":"42","author":"G Lei","year":"2024","unstructured":"Lei, G., Zhuang, L. & Gan, B. The roles of ferroptosis in cancer: tumor suppression, tumor microenvironment, and therapeutic interventions. Cancer Cell. 42 (4), 513\u2013534 (2024).","journal-title":"Cancer Cell."},{"key":"33111_CR7","doi-asserted-by":"publisher","first-page":"115323","DOI":"10.1016\/j.bcp.2022.115323","volume":"206","author":"AMP Romani","year":"2022","unstructured":"Romani, A. M. P. Cisplatin in cancer treatment. Biochem. Pharmacol. 206, 115323 (2022).","journal-title":"Biochem. Pharmacol."},{"issue":"17","key":"33111_CR8","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1089\/ars.2017.7342","volume":"29","author":"C Tonelli","year":"2018","unstructured":"Tonelli, C., Chio, I. I. C. & Tuveson, D. A. Transcriptional regulation by Nrf2. Antioxid. Redox Signal. 29 (17), 1727\u20131745 (2018).","journal-title":"Antioxid. Redox Signal."},{"issue":"13","key":"33111_CR9","doi-asserted-by":"publisher","first-page":"4777","DOI":"10.3390\/ijms21134777","volume":"21","author":"F He","year":"2020","unstructured":"He, F., Ru, X. & Wen, T. NRF2, a transcription factor for stress response and beyond. Int. J. Mol. Sci. 21 (13), 4777 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"33111_CR10","doi-asserted-by":"publisher","first-page":"1184079","DOI":"10.3389\/fonc.2023.1184079","volume":"13","author":"L Lin","year":"2023","unstructured":"Lin, L. et al. Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers. Front. Oncol. 13, 1184079 (2023).","journal-title":"Front. Oncol."},{"key":"33111_CR11","doi-asserted-by":"publisher","first-page":"111642","DOI":"10.1016\/j.fct.2020.111642","volume":"145","author":"M Adnan","year":"2020","unstructured":"Adnan, M. et al. Ginkgetin: A natural biflavone with versatile pharmacological activities. Food Chem. Toxicol. 145, 111642 (2020).","journal-title":"Food Chem. Toxicol."},{"issue":"11","key":"33111_CR12","first-page":"1245","volume":"19","author":"Y Ren","year":"2016","unstructured":"Ren, Y. et al. Ginkgetin induces apoptosis in 786-O cell line via suppression of JAK2-STAT3 pathway. Iran. J. Basic. Med. Sci. 19 (11), 1245\u20131250 (2016).","journal-title":"Iran. J. Basic. Med. Sci."},{"key":"33111_CR13","doi-asserted-by":"publisher","first-page":"154846","DOI":"10.1016\/j.phymed.2023.154846","volume":"116","author":"L Wu","year":"2023","unstructured":"Wu, L. et al. Ginkgetin suppresses ovarian cancer growth through Inhibition of JAK2\/STAT3 and MAPKs signaling pathways. Phytomedicine. 116, 154846 (2023).","journal-title":"Phytomedicine"},{"issue":"7","key":"33111_CR14","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.7150\/thno.106469","volume":"15","author":"HJ Wang","year":"2025","unstructured":"Wang, H. J. et al. TFEB promotes Ginkgetin-induced ferroptosis via TRIM25 mediated GPX4 lysosomal degradation in EGFR wide-type lung adenocarcinoma. Theranostics. 15 (7), 2991\u20133012 (2025).","journal-title":"Theranostics"},{"issue":"10","key":"33111_CR15","first-page":"765","volume":"26","author":"S Hu","year":"2023","unstructured":"Hu, S. et al. Research progress of Nrf2 and ferroptosis in tumor drug resistance. Zhongguo Fei Ai Za Zhi. 26 (10), 765\u2013773 (2023).","journal-title":"Zhongguo Fei Ai Za Zhi"},{"issue":"Pt 3","key":"33111_CR16","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.semcancer.2022.03.005","volume":"86","author":"M Kyrgiou","year":"2022","unstructured":"Kyrgiou, M. & Moscicki, A. B. Vaginal microbiome and cervical cancer. Semin. Cancer Biol. 86 (Pt 3), 189\u2013198 (2022).","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"33111_CR17","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13104-020-04996-5","volume":"13","author":"N Singh","year":"2020","unstructured":"Singh, N. et al. MDC1 depletion promotes cisplatin induced cell death in cervical cancer cells. BMC Res. Notes. 13 (1), 146 (2020).","journal-title":"BMC Res. Notes"},{"issue":"1","key":"33111_CR18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","volume":"21","author":"C Zhang","year":"2022","unstructured":"Zhang, C. et al. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol. Cancer. 21 (1), 47 (2022).","journal-title":"Mol. Cancer"},{"issue":"5","key":"33111_CR19","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen, X. et al. Broadening horizons: the role of ferroptosis in cancer. Nat. Rev. Clin. Oncol. 18 (5), 280\u2013296 (2021).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"33111_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2018.11.001","volume":"41","author":"Q Cui","year":"2018","unstructured":"Cui, Q. et al. Modulating ROS to overcome multidrug resistance in cancer. Drug Resist. Updat. 41, 1\u201325 (2018).","journal-title":"Drug Resist. Updat"},{"issue":"4","key":"33111_CR21","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3390\/cells10040758","volume":"10","author":"KS Chun","year":"2021","unstructured":"Chun, K. S., Kim, D. H. & Surh, Y. J. Role of reductive versus oxidative stress in tumor progression and anticancer drug resistance. Cells 10 (4), 758 (2021).","journal-title":"Cells"},{"key":"33111_CR22","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.biopha.2017.09.077","volume":"96","author":"J Cao","year":"2017","unstructured":"Cao, J. et al. Ginkgetin inhibits growth of breast carcinoma via regulating MAPKs pathway. Biomed. Pharmacother. 96, 450\u2013458 (2017).","journal-title":"Biomed. Pharmacother"},{"issue":"19","key":"33111_CR23","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1097\/CM9.0000000000003247","volume":"137","author":"A Alu","year":"2024","unstructured":"Alu, A. et al. Ginkgo Biloba derivative Ginkgetin inhibits breast cancer growth by regulating the miRNA-122-5p\/GALNT10 axis. Chin. Med. J. (Engl). 137 (19), 2387\u20132389 (2024).","journal-title":"Chin. Med. J. (Engl)"},{"issue":"4","key":"33111_CR24","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.3892\/ijo.2017.4116","volume":"51","author":"YJ Lee","year":"2017","unstructured":"Lee, Y. J. et al. Ginkgetin induces G2-phase arrest in HCT116 colon cancer cells through the modulation of b-Myb and miRNA34a expression. Int. J. Oncol. 51 (4), 1331\u20131342 (2017).","journal-title":"Int. J. Oncol."},{"issue":"4","key":"33111_CR25","doi-asserted-by":"publisher","first-page":"79","DOI":"10.14715\/cmb\/2019.65.4.13","volume":"65","author":"J Cheng","year":"2019","unstructured":"Cheng, J., Li, Y. & Kong, J. Ginkgetin inhibits proliferation of HeLa cells via activation of p38\/NF-\u03baB pathway. Cell. Mol. Biol. (Noisy-le-grand). 65 (4), 79\u201382 (2019).","journal-title":"Cell. Mol. Biol. (Noisy-le-grand)"},{"issue":"1","key":"33111_CR26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s13659-025-00535-6","volume":"15","author":"B Xiong","year":"2025","unstructured":"Xiong, B. et al. Ginkgetin from Ginkgo biloba: mechanistic insights into anticancer efficacy. Nat. Prod. Bioprospect. 15 (1), 50 (2025).","journal-title":"Nat. Prod. Bioprospect"},{"issue":"2","key":"33111_CR27","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1021\/acs.jnatprod.2c00959","volume":"86","author":"S Zhang","year":"2023","unstructured":"Zhang, S. et al. Ginkgo biflavones cause p53 wild-type dependent cell death in a transcription-independent manner of p53. J. Nat. Prod. 86 (2), 346\u2013356 (2023).","journal-title":"J. Nat. Prod."},{"key":"33111_CR28","doi-asserted-by":"publisher","first-page":"153370","DOI":"10.1016\/j.phymed.2020.153370","volume":"80","author":"JS Lou","year":"2021","unstructured":"Lou, J. S. et al. Ginkgetin derived from Ginkgo Biloba leaves enhances the therapeutic effect of cisplatin via ferroptosis-mediated disruption of the Nrf2\/HO-1 axis in EGFR wild-type non-small-cell lung cancer. Phytomedicine. 80, 153370 (2021).","journal-title":"Phytomedicine"},{"issue":"5","key":"33111_CR29","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3390\/cells12050804","volume":"12","author":"MS Mortensen","year":"2023","unstructured":"Mortensen, M. S., Ruiz, J. & Watts, J. L. Polyunsaturated fatty acids drive lipid peroxidation during ferroptosis. Cells 12 (5), 804 (2023).","journal-title":"Cells"},{"issue":"20","key":"33111_CR30","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1101\/gad.225680.113","volume":"27","author":"MC Jaramillo","year":"2013","unstructured":"Jaramillo, M. C. & Zhang, D. D. The emerging role of the Nrf2-Keap1 signaling pathway in cancer. Genes Dev. 27 (20), 2179\u20132191 (2013).","journal-title":"Genes Dev."},{"key":"33111_CR31","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.redox.2016.12.010","volume":"11","author":"JL Roh","year":"2017","unstructured":"Roh, J. L. et al. Nrf2 Inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis. Redox Biol. 11, 254\u2013262 (2017).","journal-title":"Redox Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33111-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33111-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33111-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T22:16:06Z","timestamp":1768342566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33111-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["33111"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-33111-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"assertion":[{"value":"6 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The studies involving animals were approved by Ethics Committee of Qinghai Red Cross Hospital(KY-2024-38). The studies were conducted in accordance with the local legislation and institutional requirements.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"1542"}}